PRISM evaluates 4D-150, a potential backbone therapy designed to provide multi-year sustained delivery of anti-VEGF ...
D Molecular Therapeutics reported 52-week Phase 2b data for 4D-150 in wet AMD, showing sustained visual acuity improvements.
Stock analysts at Leerink Partnrs upped their Q1 2025 earnings per share (EPS) estimates for Regeneron Pharmaceuticals in a ...
Kingsview Wealth Management LLC raised its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 16.5% in the fourth quarter, according to the company in its most recent ...
Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...
Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
After hours: February 12 at 4:02:16 PM EST Loading Chart for AURA ...
Want to buy London theatre tickets? You’ve come to the right place. Take a look at our wide selection of West End shows that are available to book tickets for right now. As you scroll through the ...